Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Calcium Aluminosilicate,Inapplicable
Therapeutic Area : Oncology
Study Phase : Undisclosed
Recipient : MD Anderson Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
CASAD for Severe Diarrhea in the Emergency Department
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 23, 2013
Lead Product(s) : Calcium Aluminosilicate,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : MD Anderson Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Aluminosilicate,Inapplicable
Therapeutic Area : Gastroenterology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Details : Undisclosed
Product Name : CASAD
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 03, 2012
Lead Product(s) : Calcium Aluminosilicate,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Aluminosilicate,Inapplicable
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Scott and White Hospital & Clinic | Texas A&M University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 04, 2012
Lead Product(s) : Calcium Aluminosilicate,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Scott and White Hospital & Clinic | Texas A&M University
Deal Size : Inapplicable
Deal Type : Inapplicable